News | August 10, 2021
ALS drug RADICAVA holds promise as it completes four years in US
Nearly 6,000 patients have been treated with the drug since 2017
Nearly 6,000 patients have been treated with the drug since 2017
Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
The goal for the project is the identification and optimization of anti-viral compounds.
Ibuprofen and Famotidine tablets approved by FDA
Drug formulations and biologics make impressive gains
NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level
The company posted net profit f Rs.85.45 crores for the period ended June 30, 2020.
State-of-the-art R&D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides
The company has reported total income of Rs.355.43 crores during FY 2020-21
Subscribe To Our Newsletter & Stay Updated
